Liquidia (LQDA) Depreciation & Amortization (CF) (2020 - 2026)
Liquidia (LQDA) posted Depreciation & Amortization (CF) of $400000.0 for Q2 2026, down 19.52% on a QoQ basis from $497000.0 in Q1 2026, and up 42.35% year-over-year from $281000.0 in Q2 2025.
Analysis
Liquidia (LQDA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Liquidia has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $400000.0 in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 42.35% year-over-year to $400000.0 in Q2 2026; TTM through Jun 2026 was $1.7 million, a 8.98% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 30.45% from the prior year.
- Depreciation & Amortization (CF) was $400000.0 for Q2 2026 at Liquidia, down from $497000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $1.1 million in Q3 2022, with the low at $281000.0 in Q2 2025.
- Average Depreciation & Amortization (CF) over 5 years is $580388.9, with a median of $516000.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) slumped 54.43% in 2023, then soared 42.35% in 2026.
- Over 5 years, Depreciation & Amortization (CF) stood at $566000.0 in 2022, then retreated by 10.6% to $506000.0 in 2023, then increased by 2.37% to $518000.0 in 2024, then slumped by 38.22% to $320000.0 in 2025, then increased by 25.0% to $400000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $400000.0 (Q2 2026), $497000.0 (Q1 2026), and $320000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn | - |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 1.62 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | 3.97 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 26.48 Mn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | 24.20 Mn |
| 10 | Liquidia | 6.11 Bn | 5.82 Bn | 160.92 Mn | 400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 497,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 476,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Jun 30, 2024 | 580,000.00 |
| Mar 31, 2024 | 489,000.00 |
| Dec 31, 2023 | 506,000.00 |
| Sep 30, 2023 | 514,000.00 |
| Jun 30, 2023 | 589,000.00 |
| Mar 31, 2023 | 569,000.00 |
| Dec 31, 2022 | 566,000.00 |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 947,000.00 |
| Dec 31, 2021 | 872,000.00 |
| Sep 30, 2021 | 1.55 Mn |